Document Detail

Improvement in long-term prognosis of elderly patients with acute myocardial infarction after the introduction of intravenous thrombolytic therapy.
MedLine Citation:
PMID:  9862099     Owner:  NLM     Status:  MEDLINE    
Survival rate from a "thrombolytic" period of 351 patients above 66 years of age with acute myocardial infarction (AMI) was compared with that of 289 patients from a "prethrombolytic" period. The two groups were comparable regarding sex, age, previous AMI, cerebrovascular events, morbidity and mortality during admission. Survival rates after four years were 45.0% in the "thrombolytic" group and 38.4% in the "prethrombolytic" group (p = 0.047, log rank test). Using the Cox proportional hazard analysis, thrombolytic therapy was shown to be an independent prognostic predictor in "the thrombolytic population" with a relative risk of death from day 30 to end of follow-up of 0.4 (95% confidence interval 0.2-0.8). No interaction was found between age and thrombolysis. Although only one-fifth of the patients with AMI were eligible for thrombolysis, this treatment may have contributed to the improved long-term survival.
J K Madsen; F Pedersen; H Nielsen; G V Jensen; J F Hansen
Related Documents :
20846839 - Potentially modifiable predictors of mortality in patients treated with long-term oxyge...
19032759 - B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas hig...
22573579 - First bite syndrome: incidence, risk factors, treatment, and outcomes.
22387399 - Botulinum toxin a in the treatment of spasticity - an open label study.
22595399 - Primary total knee arthroplasty using the p.f.c sigma®-rotating platform cruciate reta...
22396189 - Factors associated with favorable response to hyperbaric oxygen therapy among patients ...
12147959 - The implantable cardioverter-defibrillator. current indications and controversies.
9583819 - Composite graft replacement of the aortic root in acute dissection.
16984579 - Epidermal growth factor intralesional infiltrations can prevent amputation in patients ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian cardiovascular journal : SCJ     Volume:  32     ISSN:  1401-7431     ISO Abbreviation:  Scand. Cardiovasc. J.     Publication Date:  1998  
Date Detail:
Created Date:  1999-02-25     Completed Date:  1999-02-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9708377     Medline TA:  Scand Cardiovasc J     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  365-70     Citation Subset:  IM    
Department of Cardiology, Hvidovre Hospital, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Fibrinolytic Agents / administration & dosage,  therapeutic use
Follow-Up Studies
Myocardial Infarction / drug therapy*,  mortality*
Proportional Hazards Models
Streptokinase / administration & dosage,  therapeutic use
Survival Rate
Thrombolytic Therapy*
Time Factors
Tissue Plasminogen Activator / administration & dosage,  therapeutic use
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Plasma N-terminal atrial natriuretic peptide predicts hospitalization in patients with heart failure...
Next Document:  Unusual course of right atrial myxoma, masked by acute abdominal pain, and complicated by pulmonary ...